# Actinium Pharmaceuticals, Inc.: Form DEF 14A, filed Nov 21, 2022

- Company: [Actinium Pharmaceuticals, Inc.](/companies/atnm.md) (CIK 1388320)
- Form: DEF 14A
- Filed: 2022-11-21
- Accepted by EDGAR: Nov 21, 2022, 22:01 ET
- Period: 2022-12-08
- Accession: 0001213900-22-074269
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1388320/000121390022074269/def14a1122_actiniumpharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1388320/000121390022074269/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1388320/000121390022074269/def14a1122_actiniumpharma.htm

Filed Nov 21, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-074269. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.